Does fish oil supplementation increase cholesterol efflux capacity in familial hypercholesterolaemia?

Chan, Dick C; Ronca, Annalisa; Ying, Qidi; Pang, Jing; Croyal, Mikaël; Watts, Gerald F; Favari, Elda

Chan, Dick C; Ronca, Annalisa; Ying, Qidi; Pang, Jing; Croyal, Mikaël; Watts, Gerald F; Favari, Elda.

Afiliação

Chan DC; Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Ronca A; Department of Food and Drug, University of Parma, Parma, Italy.
Ying Q; Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Pang J; Medical School, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Croyal M; Nantes Université, CNRS, INSERM, l'institut du thorax, Nantes, France.
Watts GF; Nantes Université, CHU Nantes, Inserm, CNRS, SFR Santé, Inserm UMS 016, Nantes, France.
Favari E; CRNH-Ouest Mass Spectrometry Core Facility, Nantes, France.

Eur J Clin Invest ; 53(10): e14048, 2023 10.

Article em En | MEDLINE | ID: mdl-37386840

Assuntos

Óleos de Peixe; Hiperlipoproteinemia Tipo II; Humanos; Hiperlipoproteinemia Tipo II/tratamento farmacológico; LDL-Colesterol; Suplementos Nutricionais; HDL-Colesterol

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Óleos de Peixe / Hiperlipoproteinemia Tipo II Limite: Humans Idioma: En Revista: Eur J Clin Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google